We may have reached Peak Pharma
I’ve been thinking about this for a while from the standpoint of biology. The basic business of the pharma industry is to find small molecules that bind to large molecules and alter their activities. There are lots of these large molecules (mostly enzymes and cell surface receptors), but “lots” does not equal “infinity”. And the Read More …